Celanese vs DuPont de Nemours
CE and DD side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CE and DD compare
DuPont de Nemours is the larger company, worth 3.8 times as much as Celanese ($21.2B against $5.6B).
DuPont de Nemours grew revenue faster over the last twelve months (3.3% versus −2.2% for Celanese).
DuPont de Nemours keeps more of each dollar of sales as profit, with a net margin of 0.79% compared with −12.0% at Celanese.
Both pay dividends: Celanese yields 0.17% and DuPont de Nemours 1.5%.
DuPont de Nemours scores higher on the StockData Score (8 against 7 for Celanese), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CE | DD |
|---|---|---|
| Size and price | ||
| Market cap | $5.6B | $21.2B |
| Share price | $51.45 | $156.88 |
| Change, 1 year | 24.6% | 31.4% |
| Change, 5 years | −69.0% | −34.6% |
| Beta (5Y) | 1.12 | 1.14 |
| Employees | 11K | 15K |
| StockData Score | ||
| Total score | 7 | 8 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 1 | 4 (better) |
| Dividend score | 2 | 2 |
| Valuation | ||
| P/E | – | 349× |
| P/S | 0.6× (better) | 3.0× |
| P/B | 1.4× (better) | 1.5× |
| EV/EBITDA | 117× | 24.8× (better) |
| P/FCF | 8.0× (better) | 30.2× |
| FCF yield | 12.5% (better) | 3.3% |
| Fair value | $87.24 | $98.38 |
| Margin of safety | 41.0% (better) | −59.5% |
| Growth | ||
| Revenue growth (TTM) | −2.2% | 3.3% (better) |
| Revenue growth, 5Y average | 11.0% (better) | −9.3% |
| Profitability | ||
| Gross margin | 20.9% | 35.1% (better) |
| Operating margin | −7.1% | – |
| Net margin | −12.0% | 0.79% (better) |
| FCF margin | 7.3% | 10.0% (better) |
| Return on equity | −24.8% | 0.30% (better) |
| Return on invested capital | −3.4% | – |
| Financial health | ||
| Debt / equity | 2.88 | 0.23 (better) |
| Net debt / EBITDA | 74.43 | 1.52 (better) |
| Interest coverage | −1.0× | – |
| Current ratio | 1.45 | 2.43 (better) |
| Altman Z-score | 1.31 (better) | 0.65 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.17% | 1.5% (better) |
| Payout ratio | – | 758% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 3.6% |
| Buyback yield | – | −0.64% |
| Shareholder yield | 0.17% | 0.89% (better) |
| Ownership | ||
| Held by institutions | 111% | 73.7% |
| Held by insiders | 0.41% | 0.75% |
| Insider net buying, 12 months | $593K (better) | −$14.2M |
| Short interest, % of float | 5.6% | 2.9% |
Go deeper
- CE stock overview
- CE income statement
- CE valuation and score
- DD stock overview
- DD income statement
- DD valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.